このエントリーをはてなブックマークに追加
ID 37803
本文ファイル
著者
Marubayashi, Seiji
Yamamoto, Hiroyuki
Shibata, Satoshi
Fudaba, Yasuhiro
Fukuma, Kazuyuki
Okada, Kazuro
Ikeda, Masahiro
Maeda, Takashi
Oshiro, Yoshio
Dohi, Kiyohiko
キーワード
Erythrocytosis
Renal transplantation
Angiotensin converting enzyme inhibitor
NDC
医学
抄録(英)
Post-transplant erythrocytosis (PTE) is increasingly recognized as a complication of kidney transplantation. In this study we report the effect of the angiotesin-converting enzyme (ACE) inhibitor enalapril on hematocrit (Ht) and erythropoietin in four patients with PTE. Four renal allograft recipients with Ht greater than 51 % were studied. Treatment was initiated with enalapril administered orally at a dose of 2.5 mg/day. All the patients had an increase of hemoglobin (Hb) (17.7 ± 0.64 g/dl), Ht (54.5 ± 1.29 %) and red blood cell count (REC) (584 ± 19.2 × 10⁴/μl). All patients responded to enalapril in 8 weeks with a significant decrease of Hb, Ht, and REC. In one patient, the downward trend was more rapid and sustained, and treatment had to be discontinued to prevent the development of anemia. Serum erythropoietin showed normal in all four patients and remained unchanged during the study, even after discontinuation of enalapril treatment. Serum creatinine remained relatively stable throughout the study. These results suggest that PTE may not be dependent upon circulating erythropoietin and that enalapril treatment may be an effective treatment of PTE without renal dysfunction.
掲載誌名
Hiroshima Journal of Medical Sciences
47巻
3号
開始ページ
121
終了ページ
124
出版年月日
1998-09
出版者
Hiroshima University Medical Press
ISSN
0018-2052
NCID
言語
英語
NII資源タイプ
紀要論文
広大資料タイプ
学内刊行物(紀要等)
DCMIタイプ
text
フォーマット
application/pdf
著者版フラグ
publisher
部局名
医歯薬学総合研究科
他の一覧